Akebia Therapeutics Inc. | Key People and Executives
John P. Butler
President, Chief Executive Officer & Director
Muneer A. Satter
Chairman
Scott A. Canute
Independent Director
Ronald C. Renaud
Independent Director
Michael D. Clayman
Independent Director
Maxine Gowen
Independent Director
Michael S. Wyzga
Independent Director
Duane D. Nash
Independent Director
John P. Butler
President, Chief Executive Officer & Director
Gavin T. Malenfant
Vice President-Operations
Jason A. Amello
CFO, Treasure, Principal Accounting Officer & SVP
Rita Jain
Chief Medical Officer & Senior Vice President
Michael Rabinowitz
Vice President-Research
Karen L. Tubridy
Chief Development Officer & Senior Vice President
Michel Dahan
Chief Business Officer & Senior Vice President
John Garabo
Director-Corporate Communications
Tamara Dillon
Senior Vice President-Human Resources
Nicole R. Hadas
Secretary, Senior Vice President & General Counsel
Muneer A. Satter
Chairman
Scott A. Canute
Independent Director
Ronald C. Renaud
Independent Director
Michael D. Clayman
Independent Director
Maxine Gowen
Independent Director
Michael S. Wyzga
Independent Director
Duane D. Nash
Independent Director
| Address |
245 First Street
Cambridge Massachusetts 02142
United States
|
|
Employees
|
- |
| Website |
http://www.akebia.com |
| Updated |
07/08/2019 |
| Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for hypoxia-inducible factor. It also involves in the development and commercialization of drugs for the treatment of renal and metabolic disorders. It offers vadadustat, which is an oral therapy for the treatment of anemia due to chronic kidney disease. |
